Insiders who reported open-market trades in the last 12 months at the companies Jose Manuel Otero files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Jose Manuel Otero is a corporate insider, tracked as Chief Operating Officer of Lexeo Therapeutics, Inc. (LXEO). InsiderAlpha holds 10 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Jose Manuel Otero submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Jose Manuel Otero been buying or selling stock?
Recorded transactions: 0 open-market purchases and 8 open-market sales ($92K) across all tracked filings.
Jose Manuel Otero is Chief Operating Officer of Lexeo Therapeutics, Inc. (LXEO). 10 SEC Form 4 filings on record going back to 2025, most recently on 28 September 2026. Most recent open-market trade: sold $6K of LXEO on 19 August 2026. Lifetime open-market sales: $92K.
Recent transactions
13
The latest 13 SEC Form 4 transactions reported by Jose Manuel Otero.
InsiderAlpha's records for Jose Manuel Otero go back to 2025: 10 primary Form 4 filings, an average of 5.0 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
